文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症COVID-19合并急性肾损伤患者心功能保留但肾血流与灌注减少:一项使用超声造影的病例对照研究

Critically Ill COVID-19 Patients With Acute Kidney Injury Have Reduced Renal Blood Flow and Perfusion Despite Preserved Cardiac Function: A Case-Control Study Using Contrast-Enhanced Ultrasound.
PubMed 文献 · Shock · 2021-01-01
一句话结论重症COVID-19合并AKI患者肾大血管与微血管血流均低于健康对照,且不归因于左右心功能障碍,提示肾血管性病因可能。

这项前瞻性病例对照研究用超声造影评估肾灌注、多普勒分析肾大血管血流、超声心动图评估左右心功能及心输出量,比较COVID-19合并AKI患者、脓毒性休克患者与健康志愿者的差异。结果显示,与健康对照相比,COVID-19合并AKI患者灌注指数(3415 vs 548 a.u.,P=0.001)和肾血容量(7794 vs 3338 a.u.,P=0.04)降低,肾动脉时间平均峰值流速也降低(36.6 cm/s vs 20.9 cm/s,P=0.004),而心脏指数两组相似(2.8 L/min/m2 vs 3.7 L/min/m2,P=0.07)。COVID-19与脓毒性休克患者之间超声造影或心脏参数无差异,但脓毒性休克患者灌注变量更不均匀。结论提示COVID-19相关AKI可能存在肾血管性发病机制。

要点

  • 重症COVID-19合并AKI患者超声造影灌注指数低于健康对照(3415 vs 548 a.u.,P=0.001)。
  • 重症COVID-19合并AKI患者肾血容量低于健康对照(7794 vs 3338 a.u.,P=0.04)。
  • 肾动脉时间平均峰值流速低于健康对照(36.6 cm/s vs 20.9 cm/s,P=0.004),但心脏指数两组相似(2.8 L/min/m2 vs 3.7 L/min/m2,P=0.07)。
  • COVID-19合并AKI与脓毒性休克患者之间超声造影或心脏参数无差异,脓毒性休克患者灌注变量更不均匀。
  • 肾血流减少似乎不是左右心功能障碍的结果,肾血管性发病机制可能。

适用人群与场景

  • 重症COVID-19合并急性肾损伤患者、脓毒性休克患者及健康志愿者。

研究设计与关键结果

  • 前瞻性病例对照研究,比较重症COVID-19合并AKI患者、脓毒性休克患者与健康志愿者的肾灌注、肾大血管血流及心功能。
  • 超声造影灌注指数:COVID-19合并AKI组3415 vs 健康对照548 a.u.,P=0.001;肾血容量:7794 vs 3338 a.u.,P=0.04。
  • 肾动脉时间平均峰值流速:COVID-19合并AKI组36.6 cm/s vs 健康对照20.9 cm/s,P=0.004。
  • 心脏指数:COVID-19合并AKI组2.8 L/min/m2 vs 健康对照3.7 L/min/m2,P=0.07。
  • COVID-19合并AKI与脓毒性休克患者之间超声造影或心脏参数无差异,脓毒性休克患者灌注变量更不均匀。

证据类型、等级与局限

  • 证据类型:前瞻性病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,COVID-19相关AKI的肾血管性发病机制似乎可能,肾血流减少似乎不是左右心功能障碍的结果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute kidney injury (AKI) is a common complication of COVID-19 critical illness but the pathophysiology is uncertain. Some evidence has indicated that a vascular aetiology may be implicated. We used contrast-enhanced ultrasound (CEUS) and echocardiography to study renal perfusion and global blood flow and compared our findings with measurements taken in a group of septic shock patients and healthy volunteers.

METHODS: Prospective case-control study. Renal perfusion variables were assessed with CEUS; macrovascular blood flow was assessed using Doppler analysis of large renal vessels; echocardiography was used to assess right and left heart function and cardiac output.

RESULTS: CEUS-derived parameters were reduced in COVID-19 associated AKI compared with healthy controls (perfusion index 3,415 vs. 548 a.u., P = 0·001; renal blood volume 7,794 vs. 3,338 a.u., P = 0·04). Renal arterial flow quantified using time averaged peak velocity was also reduced compared with healthy controls (36·6 cm/s vs. 20·9 cm/s, P = 0.004) despite cardiac index being similar between groups (2.8 L/min/m2 vs. 3.7 L/min/m2, P = 0.07). There were no differences in CEUS-derived or cardiac parameters between COVID-19 and septic shock patients but patients with septic shock had more heterogeneous perfusion variables.

CONCLUSION: Both large and small vessel blood flow is reduced in patients with COVID-19 associated AKI compared with healthy controls, which does not appear to be a consequence of right or left heart dysfunction. A reno-vascular pathogenesis of COVID-19 AKI seems likely.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Watchorn J, Huang DY, Joslin J, et al. Critically Ill COVID-19 Patients With Acute Kidney Injury Have Reduced Renal Blood Flow and Perfusion Despite Preserved Cardiac Function: A Case-Control Study Using Contrast-Enhanced Ultrasound. Shock. 2021. PMID: 32890313. doi:10.1097/SHK.0000000000001659

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。